Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Talis Biomedical Corporation TLIS OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
30/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Il y a eu 50 transactions d'initiés récentes enregistrées pour Talis Biomedical Corporation (TLIS), dont 37 achats et 5 ventes. Le total des achats d'initiés s'élève à $12.33M et le total des ventes d'initiés à $47.41K.

Les initiés notables ayant une activité récente comprennent Leonard Braden Michael, Young John T. Jr., Ferrari Patricia. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — TLIS

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2024-09-06 Leonard Braden Michael 10 Percent Owner Achat Informatif 25,000 $1.48 $37.1K 248,702
2024-09-05 Leonard Braden Michael 10 Percent Owner Achat Informatif 5,100 $1.40 $7.14K 223,702
2024-09-03 Leonard Braden Michael 10 Percent Owner Achat Informatif 500 $4.00 $2K 218,602
2024-08-30 Leonard Braden Michael 10 Percent Owner Achat Informatif 151 $4.25 $641.75 218,602
2024-08-28 Leonard Braden Michael 10 Percent Owner Achat Informatif 1,215 $3.96 $4.81K 217,951
2024-08-26 Leonard Braden Michael 10 Percent Owner Achat Informatif 13,167 $3.90 $51.32K 216,736
2024-08-14 Leonard Braden Michael 10 Percent Owner Inconnu - - - 203,569
2024-07-31 Young John T. Jr. Director Inconnu - - - -
2024-07-31 Ferrari Patricia Director Inconnu - - - -
2023-08-01 Lukowiak Andrew A Officer Inconnu - - - -
2023-08-01 Lukowiak Andrew A President Attribution de RSU 30,575 $7.42 $226.87K 30,575
2023-07-17 Markovich Rebecca Interim CFO Attribution de RSU 13,071 $7.65 $99.99K 13,071
2023-06-09 Popovits Kimberly J Director Attribution de RSU 95,000 $0.50 $47.5K 95,000
2023-06-09 Scott Randal W. Director Attribution de RSU 95,000 $0.50 $47.5K 95,000
2023-06-09 Dreismann Heinrich Director Attribution de RSU 5,466 $0.50 $2.73K 5,466
2023-06-09 Posard Matthew L. Director Attribution de RSU 95,000 $0.50 $47.5K 95,000
2023-06-09 Ismagilov Rustem F. Director Attribution de RSU 95,000 $0.50 $47.5K 95,000
2023-06-09 Gilliam Melissa Director Attribution de RSU 95,000 $0.50 $47.5K 95,000
2023-06-09 Baker Bros. Advisors Lp 10 Percent Owner Attribution de RSU 23,685 $0.50 $11.95K 23,685
2023-05-19 Dreismann Heinrich Director Inconnu - - - -
2023-05-19 Dreismann Heinrich Director Attribution de RSU 190,000 $0.46 $87.4K 190,000
2023-04-21 Markovich Rebecca Interim CFO Cession 70,000 $0.49 $34.3K -
2023-04-07 Moody John Roger Jr Chief Financial Officer Attribution de RSU 300,000 $0.49 $147K 300,000
2023-04-07 Kelley Robert J. Chief Executive Officer Attribution de RSU 500,000 $0.49 $245K 500,000
2023-03-10 Cheong Raymond Director Inconnu - - - -
2022-06-10 Baker Bros. Advisors Lp 10 Percent Owner Attribution de RSU 95,000 $1.00 $95K 95,000
2022-06-10 Popovits Kimberly J Director Attribution de RSU 95,000 $1.00 $95K 95,000
2022-06-10 Scott Randal W. Director Attribution de RSU 95,000 $1.00 $95K 95,000
2022-06-10 Baker Brothers Life Sciences Lp Director Attribution de RSU 95,000 - - 95,000
2022-06-10 Posard Matthew L. Director Attribution de RSU 95,000 $1.00 $95K 95,000
2022-06-10 Ismagilov Rustem F. Director Attribution de RSU 95,000 - - 95,000
2022-06-10 Gilliam Melissa Director Attribution de RSU 95,000 - - 95,000
2022-06-01 Moody John Roger Jr Chief Financial Officer Attribution de RSU 500,000 - - 500,000
2022-06-01 Kelley Robert J. Chief Executive Officer Attribution de RSU 723,560 - - 723,560
2021-12-08 Kelley Robert J. Chief Executive Officer Attribution de RSU 450,000 $4.28 $1.93M 450,000
2021-12-01 Blaser Brian J President and CEO Inconnu - - - -
2021-12-01 Blaser Brian J President and CEO Attribution de RSU 625,000 - - 625,000
2021-11-18 Baker Bros. Advisors Lp 10 Percent Owner Achat Informatif 50,000 $4.37 $218.25K 7,053,176
2021-10-02 Moody John Roger Jr Chief Financial Officer Attribution de RSU 130,000 $6.17 $802.1K 579,897
2021-10-02 Liu Douglas Chief Operating Officer Attribution de RSU 200,000 $6.17 $1.23M 514,685
2021-10-02 Kelley Robert J. Chief Commercial Officer Attribution de RSU 130,000 $6.17 $802.1K 427,202
2021-08-30 Popovits Kimberly J Interim CEO Attribution de RSU 550,000 $9.06 $4.98M 550,000
2021-08-13 Ramakrishnan Ramesh Officer Exercice d'Options (Vente) 8,741 $1.50 $13.11K -
2021-05-17 Scott Randal W. Director Achat Informatif 11,000 $10.11 $111.21K 20,000
2021-05-14 Scott Randal W. Director Achat Informatif 9,000 $10.16 $91.44K 9,000
2021-03-16 Hilleman Jeryl L Director Inconnu - - - -
2021-03-16 Hilleman Jeryl L Director Attribution de RSU 35,112 $17.60 $617.97K 35,112
2021-02-17 Baker Bros. Advisors Lp 10 Percent Owner Exercice d'Options (Vente) 10,214,159 - - -
2021-02-17 Popovits Kimberly J Director Conversion (Vente) 128,655 - - -
2021-02-17 Scott Randal W. Director Conversion (Vente) 432,749 - - -
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message